+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genmab AS - logo

Genmab is a leading biotechnology company that focuses on developing innovative antibody products. Arzerra is the company’s first marketed antibody and is approved to treat chronic lymphocytic leukemia (CLL) patients in all major markets. Another product, Darzalex, has been approved in the United States for the treatment of patients with multiple myeloma. Genmab was founded in Copenhagen, Denmark in 1999 and employs around 200 people.

Global T-cell lymphoma Market 2022-2026 - Product Thumbnail Image

Global T-cell lymphoma Market 2022-2026

  • Report
  • August 2022
  • 120 Pages
  • Global
From
T-Cell Lymphoma Market - Global Industry Size, Share, Trends Opportunity, and Forecast 2018-2028 - Product Thumbnail Image

T-Cell Lymphoma Market - Global Industry Size, Share, Trends Opportunity, and Forecast 2018-2028

  • Report
  • October 2023
  • 175 Pages
  • Global
From
Chronic Lymphocytic Leukemia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Thumbnail Image

Chronic Lymphocytic Leukemia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • February 2024
  • 184 Pages
  • Global
From
Global T-Cell Lymphoma - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Global T-Cell Lymphoma - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 132 Pages
  • Global
From
Non-Hodgkin Lymphoma Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Non-Hodgkin Lymphoma Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 112 Pages
  • Global
From
C-MET Non-Small Cell Lung Cancer (c-MET+ NSCLC) - Pipeline Insight, 2024 - Product Thumbnail Image

C-MET Non-Small Cell Lung Cancer (c-MET+ NSCLC) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Acute Myeloid Leukemia - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029 - Product Thumbnail Image

Acute Myeloid Leukemia - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

  • Report
  • February 2024
  • 137 Pages
  • Global
From
Diffuse Large B-cell Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Diffuse Large B-cell Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Primary Mediastinal Large B-Cell Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Primary Mediastinal Large B-Cell Lymphoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 120 Pages
  • Global
From
Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics Global Market Report 2024 - Product Thumbnail Image

Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
EPKINLY Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

EPKINLY Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • Global
From
Chronic lymphocytic leukemia - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic lymphocytic leukemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 210 Pages
  • Global
From
Acute Lymphoblastic Leukemia Therapeutics Market Report and Forecast 2024-2032 - Product Thumbnail Image

Acute Lymphoblastic Leukemia Therapeutics Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
mRNA Therapeutics and Vaccines Market, 2020-2030 - Product Thumbnail Image

mRNA Therapeutics and Vaccines Market, 2020-2030

  • Report
  • January 2021
  • 253 Pages
  • Global
From
Non-Viral Drug Delivery Systems (Focus on Intracellular Technologies and Intracellular Biologics) Market by Type of Molecule and Key Geographies: Industry Trends and Global Forecasts 2021-2030 - Product Thumbnail Image

Non-Viral Drug Delivery Systems (Focus on Intracellular Technologies and Intracellular Biologics) Market by Type of Molecule and Key Geographies: Industry Trends and Global Forecasts 2021-2030

  • Report
  • February 2021
  • 256 Pages
  • Global
From
Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030 - Product Thumbnail Image

Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030

  • Report
  • April 2020
  • 536 Pages
  • Global
From
Rybrevant Bispecific Antibody Patent, Sales & Clinical Trials Outlook 2028 - Product Thumbnail Image

Rybrevant Bispecific Antibody Patent, Sales & Clinical Trials Outlook 2028

  • Report
  • October 2021
  • 78 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2024

  • Report
  • April 2024
  • 500 Pages +
  • Global
From
Marginal Zone Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Marginal Zone Lymphoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 150 Pages
  • Global
From
Co-promotion and Co-marketing in Pharmaceuticals and Biotechnology 2016-2024 - Product Thumbnail Image

Co-promotion and Co-marketing in Pharmaceuticals and Biotechnology 2016-2024

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Loading Indicator